cisplatin,pembrolizumab,gemcitabine
merck
['pembro', 'cisplatin', 'hcrn gu14-188', 'urothelial', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'gemcitabine']
hcrn gu14-188: phase ib/ii study of neoadjuvant pembrolizumab and chemotherapy for t2-4an0m0 urothelial cancer. presented by . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology